Ownership history in BRANDYWINE MANAGERS, LLC · 29 quarters on record
This page tracks every 13F SEC filing in which BRANDYWINE MANAGERS, LLC reported a position in ALNYLAM PHARMACEUTICALS INC (ALNY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 3,618 | -100 | -2.7% | 0.71% | $1.4M | $397.65 |
| 2025 Q3 | REDUCED | 3,718 | -500 | -11.9% | 1.63% | $1.7M | $456.00 |
| 2025 Q2 | REDUCED | 4,218 | -130 | -3.0% | 1.37% | $1.4M | $326.09 |
| 2025 Q1 | UNCHANGED | 4,348 | — | 0% | 1.41% | $1.2M | $270.02 |
| 2024 Q4 | UNCHANGED | 4,348 | — | 0% | 1.08% | $1.0M | $235.31 |
| 2024 Q3 | UNCHANGED | 4,348 | — | 0% | 1.29% | $1.2M | $275.03 |
| 2024 Q2 | UNCHANGED | 4,348 | — | 0% | 1.12% | $1.1M | $243.00 |
| 2024 Q1 | UNCHANGED | 4,348 | — | 0% | 0.64% | $650K | $149.45 |
| 2023 Q4 | REDUCED | 4,348 | -260 | -5.6% | 0.91% | $832K | $191.41 |
| 2023 Q3 | UNCHANGED | 4,608 | — | 0% | 1.38% | $816K | $177.10 |
As of 2025 Q4 — sorted by position size